company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5710000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13832000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19542000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19542000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-444000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-28000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-472000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20014000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20014000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20014000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1637000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21651000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-28.39
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-28.39
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,762761.0
aTyr Pharma Inc,LIFE,,0001339970,2013.0,FY,2013-01-01,2013-12-31,2016-03-30 16:13:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-28.39
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6777000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16777000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23554000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23554000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-832000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,36000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-796000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24350000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24350000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24350000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,416000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24766000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-29.69
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-29.69
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,834221.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,FY,2014-01-01,2014-12-31,2017-03-16 16:16:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-29.69
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1689000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4341000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6030000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6030000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-832000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,36000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-796000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6826000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,788000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6038000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6038000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6038000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.95
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.95
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,834221.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.95
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5088000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12436000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17524000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17524000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17524000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-788000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18312000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18312000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,416000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18728000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-22.74
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-22.74
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,843817.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-22.74
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1821000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4410000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6231000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6231000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6231000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-400000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6631000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6631000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,139000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6770000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-8.02
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-8.02
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,843817.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q3,2014-07-01,2014-09-30,2015-11-10 16:38:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-8.02
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3267000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8026000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11293000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11293000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11293000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-388000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11681000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11681000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,277000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11958000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-14.72
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-14.72
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,836533.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-14.72
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1725000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3638000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5363000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5363000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5363000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-225000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5588000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5588000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,139000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5727000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.85
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.85
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,836533.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q2,2014-04-01,2014-06-30,2015-08-12 16:18:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.85
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1542000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4388000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5930000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5930000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5930000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-163000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6093000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6093000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,138000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6231000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-7.87
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-7.87
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,791283.0
aTyr Pharma Inc,LIFE,,0001339970,2014.0,Q1,2014-01-01,2014-03-31,2015-06-18 16:22:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-7.87
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13112000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34504000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47616000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47616000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-357000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-357000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47973000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47973000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47973000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,15000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47988000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15800000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.03
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15800000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.03
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15838353.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,FY,2015-01-01,2015-12-31,2018-03-20 16:50:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.03
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3813000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12670000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16483000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16483000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-357000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-357000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16840000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,347000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16493000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16493000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16493000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15800000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.58
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15800000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.58
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15838353.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.58
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3574000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7739000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11313000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11313000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11313000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-16000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11329000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11329000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11329000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23600000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23600000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23581001.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:41:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9299000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21834000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31133000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31133000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31133000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-347000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31480000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31480000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,15000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31495000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23600000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-10.61
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23600000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-10.61
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23581001.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-10.61
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10988000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26175000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37163000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37163000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-832000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,36000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-796000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37959000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,441000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37518000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37518000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,15000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37533000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23600000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-17.56
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23600000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-17.56
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23581001.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-17.56
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3396000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7502000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10898000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10898000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10898000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-182000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11080000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11080000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,15000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11095000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.74
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.74
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14901473.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2,2015-04-01,2015-06-30,2016-08-10 16:19:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.74
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5725000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14095000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19820000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19820000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19820000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-331000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20151000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20151000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,15000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20166000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-10.13
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-10.13
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14901473.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-10.13
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9235000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22846000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32081000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32081000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-832000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,36000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-796000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32877000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,57000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32820000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32820000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,154000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32974000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-25.1
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-25.1
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14901473.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-25.1
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7564000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18982000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26546000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26546000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-832000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,36000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-796000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27342000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,14000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27328000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27328000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,278000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27606000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-31.21
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-31.21
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,966322.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-31.21
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2329000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6593000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8922000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8922000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8922000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-149000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9071000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9071000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9071000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-9.39
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1000000.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-9.39
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,966322.0
aTyr Pharma Inc,LIFE,,0001339970,2015.0,Q1,2015-01-01,2015-03-31,2015-06-18 16:22:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-9.39
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15094000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42846000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57940000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-57940000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,65000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,36000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-57904000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-49000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-57855000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-57855000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-57855000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23700000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.44
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23700000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.44
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23681019.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,FY,2016-01-01,2016-12-31,2019-03-26 17:28:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.44
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3470000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10395000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13865000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13865000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13865000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,46000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13819000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13819000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13819000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23800000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23800000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23696511.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q3,2016-07-01,2016-09-30,2016-11-14 15:41:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4126000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11307000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15433000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15433000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15433000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,50000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15383000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15383000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15383000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23700000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23700000.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23672527.0
aTyr Pharma Inc,LIFE,,0001339970,2016.0,Q2,2016-04-01,2016-06-30,2016-08-10 16:19:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17078000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30067000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47145000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47145000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47145000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47145000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1062000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48207000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-48207000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1800000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-26.13
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1800000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-26.13
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1845033.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,FY,2017-01-01,2017-12-31,2020-03-26 16:16:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-26.13
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5890000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5310000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11200000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11200000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11200000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,788000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10412000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1062000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11474000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11474000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1800000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.37
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1800000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.37
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1845033.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.37
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11188000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24757000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35945000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35945000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35945000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-788000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36733000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36733000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36733000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26000000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.41
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26000000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.41
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25818008.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.41
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3694000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7133000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10827000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10827000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10827000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-363000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11190000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11190000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11190000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26000000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26000000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25818008.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 16:07:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7494000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17624000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25118000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25118000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25118000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-425000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25543000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25543000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25543000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23800000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.07
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23800000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.07
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23810112.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.07
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3487000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8420000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11907000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11907000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11907000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-231000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12138000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12138000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12138000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23800000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23800000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23810112.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 16:17:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4007000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9204000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13211000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13211000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13211000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-194000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13405000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13405000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13405000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23900000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23900000.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23739057.0
aTyr Pharma Inc,LIFE,,0001339970,2017.0,Q1,2017-01-01,2017-03-31,2018-05-15 16:06:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12435000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20385000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32820000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32820000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32820000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32820000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1695000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34515000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34515000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2100000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-16.11
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2100000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-16.11
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2141961.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,FY,2018-01-01,2018-12-31,2020-03-26 16:16:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-16.11
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2414000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3549000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5963000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5963000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5963000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,889000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5074000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1248000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6322000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6322000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2100000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.01
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2100000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.01
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2141961.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.01
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10021000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16836000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26857000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26857000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26857000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-889000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27746000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-447000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28193000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28193000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.95
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.95
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29858393.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.95
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15911000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22146000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38057000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38057000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38057000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-101000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38158000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1509000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.34
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.34
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29858393.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.34
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2475000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4202000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6677000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6677000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6677000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-437000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7114000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7114000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7114000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29858393.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q3,2018-07-01,2018-09-30,2018-11-14 16:07:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7546000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12634000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20180000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20180000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20180000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-452000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20632000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-447000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21079000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21079000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29700000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29700000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29842721.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17130000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25077000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42207000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42207000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42207000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-27000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42234000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1509000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43743000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43743000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29700000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.47
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29700000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.47
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29842721.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.47
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3476000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6484000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9960000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9960000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9960000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-452000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10412000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10412000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10412000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29700000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29700000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29842721.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q2,2018-04-01,2018-06-30,2018-08-14 16:17:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4070000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6150000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10220000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10220000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10220000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10220000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-447000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10667000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29795466.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1,2018-01-01,2018-03-31,2019-05-14 16:06:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17141000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27013000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44154000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-44154000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-44154000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,194000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43960000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1509000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45469000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45469000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.54
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29600000.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.54
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29795466.0
aTyr Pharma Inc,LIFE,,0001339970,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.54
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,422000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,422000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,422000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9352000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14048000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23400000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22978000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22978000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22978000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-785000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23763000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-160000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23603000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3400000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-7.03
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3400000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-7.03
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3355600.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,FY,2019-01-01,2019-12-31,2020-03-26 16:16:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-7.03
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,144000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,144000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,144000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2516000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3590000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6106000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5962000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5962000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5962000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-171000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6133000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-160000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5973000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3400000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.76
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3400000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.76
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3355600.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.76
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,278000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,278000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,278000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6836000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10458000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17294000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17016000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17016000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17016000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-614000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17630000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17630000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3800000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.64
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3800000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.64
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3846249.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.64
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,278000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,278000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,278000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9250000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14007000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23257000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22979000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22979000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,889000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22090000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1862000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23952000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23952000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3800000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.3
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3800000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.3
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3846249.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.3
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,184000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,184000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,184000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1883000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3799000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5682000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5498000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5498000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5498000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-147000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5645000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5645000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3800000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.47
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3800000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.47
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3846249.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q3,2019-07-01,2019-09-30,2019-11-14 16:16:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.47
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,94000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,94000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,94000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4953000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6659000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11612000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11518000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11518000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11518000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-467000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11985000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11985000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3200000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.75
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3200000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.75
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3244920.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.75
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,94000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,94000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,94000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9842000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14410000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24252000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24158000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24158000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,452000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23706000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1715000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25421000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25421000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3200000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-7.94
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3200000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-7.94
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3244920.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-7.94
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,94000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,94000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,94000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2421000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3314000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5735000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5641000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5641000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5641000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-207000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5848000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5848000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3200000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.8
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3200000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.8
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3244920.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 16:54:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.8
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2532000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3345000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5877000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5877000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5877000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5877000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-260000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6137000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6137000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2418674.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.54
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2418674.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.54
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2400000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1,2019-01-01,2019-03-31,2020-05-12 17:06:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.54
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10897000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17580000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28477000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28477000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28477000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28477000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-1508000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29985000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29985000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2418674.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-12.4
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2418674.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-12.4
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2400000.0
aTyr Pharma Inc,LIFE,,0001339970,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-12.4
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8487000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8487000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8487000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9410000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14319000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23729000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15242000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15242000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15242000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-632000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15873000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-161000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15712000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6881791.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.28
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6884797.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.28
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7000000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.28
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8065000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8065000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8065000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2590000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3616000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6206000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1859000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1859000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1859000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-107000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1753000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1754000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6881791.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6884797.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7000000.0
aTyr Pharma Inc,LIFE,,0001339970,2020.0,Q1,2020-01-01,2020-03-31,2020-05-12 17:06:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
